Newsletter Subject

Insider Buying Activity Uncovered - 7 Stocks On The Rise

From

insidetraderalerts.com

Email Address

editor@insidetraderalerts.com

Sent On

Wed, Jan 17, 2024 11:46 PM

Email Preheader Text

This is a must read. If you cannot see this email properly, please click ---------------------------

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Investor Alert: Essential Element To AI Revolution Found In Nevada]( [See how the one key element found in American soil has become indispensable.]( --------------------------------------------------------------- January 17, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Blue Chips And Billionaires Quietly Investing In "The New Oil"]( re as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more. [Learn more about the global race to secure supply and what it means for investors.]( --------------------------------------------------------------- [USA Compression Partners, LP]( Ticker: [USAC]( Recent Price: $24.54 Average Analyst Price Target: $23.50 (-0.27%) Market Cap: $2.41B Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Options Exercised and fully kept 1,681,689 $33,650,597 2 Days Ago Recent Analyst Action: Jeremy Tonet, analyst at J.P. Morgan, reiterates coverage on [USA Compression Partners, LP (USAC)]( in the Energy sector with a Sell rating and a price target of $22 (1 month ago). Here are 3rd party ratings for [USAC](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Bottom 10% (225 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [America's Cash Bubble Set to Burst on January 31, 2024]( the first time I’ve ever heard of… we know the exact day (and time) a bubble is going to burst. This is insane and something we only have access to because of Jason’s findings (that he’s sharing with his ultra-elite clients). To find out what the cash bubble is and why you’re vulnerable to it without even realizing... [Watch His Free Video Here]( --------------------------------------------------------------- [BlackRock Capital Allocation Trust]( Ticker: [BCAT]( Recent Price: $14.95 Average Analyst Price Target: n/a (-) Market Cap: $1.62B Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 157,211 $2,351,877 2 Days Ago Here are 3rd party ratings for [BCAT](: - TipRanks.com: No Consensus - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Alpine Immune Sciences, Inc.]( Ticker: [ALPN]( Recent Price: $20.63 Average Analyst Price Target: $30.25 (-) Market Cap: $1.20B Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 145,251 $1,850,498 2 Days Ago Director Informative Buy Options Exercised and fully kept 145,251 $1,850,498 2 Days Ago Recent Analyst Action: Gregory Renza, analyst at RBC Capital, reiterates coverage on [Alpine Immune Sciences, Inc. (ALPN)]( in the Healthcare sector with a Buy rating and a price target of $29 (1 week ago). Here are 3rd party ratings for [ALPN](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 35% (89 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Holding NVDA? Read This Now]( Wall Street Veteran Marc Chaikin just detailed why he's avoiding NVDA and buying this overlooked A.I. stock instead. [Learn more here.]( --------------------------------------------------------------- [OPKO Health, Inc.]( Ticker: [OPK]( Recent Price: $0.94 Average Analyst Price Target: $3.75 (2.72%) Market Cap: $727.29M Role Transaction Description No. of Shares Amount Date CEO & Chairman, Director, >10% Owner Informative Buy Non Open Market Buy 1,000,000 $950,000 2 Days Ago Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [OPKO Health, Inc. (OPK)]( in the Healthcare sector with a Buy rating and a price target of $3 (2 months ago). Here are 3rd party ratings for [OPK](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 39% (152 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [KalVista Pharmaceuticals, Inc.]( Ticker: [KALV]( Recent Price: $12.83 Average Analyst Price Target: $21.00 (1.96%) Market Cap: $443.39M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 26,246 $333,779 2 Days Ago Recent Analyst Action: Andrew Fein, analyst at H.C. Wainwright, reiterates coverage on [KalVista Pharmaceuticals, Inc. (KALV)]( in the Healthcare sector with a Buy rating and a price target of $16 (1 month ago). Here are 3rd party ratings for [KALV](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 35% (98 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is History's Favorite Asset Powering Today's Tech Revolution?]( AI Revolution is moving towards a world where technology isn't just an industry, but the backbone of all industries. Yet at the very foundation of this technology are rare metals. As the arms race for AI computing power heats up, in a twist of fate, so does Mining. As global superpowers refine the technology of tomorrow they are also in a race against each other to secure the resources to make them. [What this means for investors and a U.S. company that may sit at the epicenter of this transformation.]( --------------------------------------------------------------- [BJ's Restaurants, Inc.]( Ticker: [BJRI]( Recent Price: $31.31 Average Analyst Price Target: $36.80 (0.26%) Market Cap: $727.55M Role Transaction Description No. of Shares Amount Date Sr. VP Brewing Ops Informative Buy Non Open Market Buy 2,355 $75,030 2 Days Ago Recent Analyst Action: Brian Bittner, analyst at Oppenheimer, reiterates coverage on [BJ's Restaurants, Inc. (BJRI)]( in the Consumer Cyclical sector with a Buy rating and a price target of $42 (1 week ago). Here are 3rd party ratings for [BJRI](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 33% (84 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Destra Multi-Alternative Fund]( Ticker: [DMA]( Recent Price: $6.48 Average Analyst Price Target: n/a (-) Market Cap: $58.08M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 10,053 $64,942 2 Days Ago Here are 3rd party ratings for [DMA](: - TipRanks.com: No Consensus - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Breaking: Uncle Sam Must Secure "The Seeds of Technology"]( Earth Elements are a group of metals crucial for semiconductor chips, renewable energy, electric vehicles, and MUCH more. The problem is China accounts for 70% of global mine production of them. For the U.S. and Canada, it has become a matter of national security. [Learn more about this mega trend and one company hoping to meet demand.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software

Marketing emails from insidetraderalerts.com

View More
Sent On

04/03/2024

Sent On

04/03/2024

Sent On

04/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.